In AD mouse models, the deletion of CHI3L1 reduced Aβ burden and increased the expression of the microglial lysosomal marker CD68 around plaques, suggesting that CHI3L1 may inhibit glial phagocytic activation, thereby promoting amyloid accumulation [144]. Here, CHI3L1 is linked to Alzheimer disease.